Canaccord Genuity Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)

October 1, 2024 6:50 AM EDT Send to a Friend
Canaccord Genuity analyst Whitney Ijem reiterated a Buy rating and $16.00 price target on Tenaya Therapeutics Inc (NASDAQ: TNYA).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login